KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Preferred Dividend Payments (2020 - 2023)

Boston Scientific's Preferred Dividend Payments history spans 4 years, with the latest figure at $9.0 million for Q2 2023.

  • For Q2 2023, Preferred Dividend Payments fell 35.71% year-over-year to $9.0 million; the TTM value through Mar 2024 reached $9.0 million, down 83.64%, while the annual FY2023 figure was $23.0 million, 58.18% down from the prior year.
  • Preferred Dividend Payments for Q2 2023 was $9.0 million at Boston Scientific, down from $14.0 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $14.0 million in Q3 2020 and bottomed at $5.0 million in Q2 2020.
  • The 4-year median for Preferred Dividend Payments is $14.0 million (2020), against an average of $12.8 million.
  • The largest annual shift saw Preferred Dividend Payments soared 180.0% in 2021 before it crashed 35.71% in 2023.
  • A 4-year view of Preferred Dividend Payments shows it stood at $14.0 million in 2020, then fell by 7.14% to $13.0 million in 2021, then changed by 0.0% to $13.0 million in 2022, then crashed by 30.77% to $9.0 million in 2023.
  • Per Business Quant, the three most recent readings for BSX's Preferred Dividend Payments are $9.0 million (Q2 2023), $14.0 million (Q1 2023), and $13.0 million (Q4 2022).